Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016246585> ?p ?o ?g. }
Showing items 1 to 96 of
96
with 100 items per page.
- W2016246585 endingPage "189" @default.
- W2016246585 startingPage "184" @default.
- W2016246585 abstract "Topical glucocorticosteroids are the gold standard in treatment of atopic dermatitis (AD). Recently, topical calcineurin inhibitors have been developed for treatment of this condition. This study compared efficacy and safety of 0.1% methylprednisolone aceponate (MPA) ointment with 0.03% tacrolimus ointment for 3 weeks, in children and adolescents with severe to very severe flare of AD.The primary end point was treatment success, defined as a score of 'clear' or 'almost clear' in the static Investigator's Global Assessment (IGA) score. Secondary end points were the percentage change in the Eczema Area and Severity Index (EASI) and patients' assessment of itch and sleep, Children's Dermatology Life Quality Index, patient's assessment of global response, affected Body Surface Area and medication costs.265 patients were randomized to either MPA (n = 129) or tacrolimus (n = 136) treatment, 257 patients completed the study. Methylprednisolone aceponate 0.1% ointment once daily provided rapid and relevant clinical benefit. Tacrolimus 0.03% ointment twice daily was equally effective with regard to success rate. Methylprednisolone aceponate was superior to tacrolimus for EASI, itch and sleep. Both treatments were well tolerated. Drug-related adverse events were only observed in the tacrolimus group. Medication costs were significantly lower for MPA.While both treatment groups showed similar efficacy results regarding treatment success (IGA), significant advantages were observed for EASI, itch and sleep with MPA 0.1%. These advantages and the significantly lower treatment costs highlight the benefits of MPA treatment, underlining its first-line role in treatment of children and adolescents with severe AD." @default.
- W2016246585 created "2016-06-24" @default.
- W2016246585 creator A5021862730 @default.
- W2016246585 creator A5027225972 @default.
- W2016246585 creator A5030110134 @default.
- W2016246585 creator A5042529442 @default.
- W2016246585 creator A5045943832 @default.
- W2016246585 creator A5048797041 @default.
- W2016246585 creator A5074921066 @default.
- W2016246585 date "2007-01-15" @default.
- W2016246585 modified "2023-10-15" @default.
- W2016246585 title "Efficacy and safety of methylprednisolone aceponate ointment 0.1% compared to tacrolimus 0.03% in children and adolescents with an acute flare of severe atopic dermatitis" @default.
- W2016246585 cites W1962004675 @default.
- W2016246585 cites W2004753373 @default.
- W2016246585 cites W2022137053 @default.
- W2016246585 cites W2044053588 @default.
- W2016246585 cites W2047826268 @default.
- W2016246585 cites W2065839842 @default.
- W2016246585 cites W2070602264 @default.
- W2016246585 cites W2117359358 @default.
- W2016246585 cites W2171509266 @default.
- W2016246585 cites W2428789477 @default.
- W2016246585 doi "https://doi.org/10.1111/j.1398-9995.2006.01269.x" @default.
- W2016246585 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17298428" @default.
- W2016246585 hasPublicationYear "2007" @default.
- W2016246585 type Work @default.
- W2016246585 sameAs 2016246585 @default.
- W2016246585 citedByCount "81" @default.
- W2016246585 countsByYear W20162465852012 @default.
- W2016246585 countsByYear W20162465852013 @default.
- W2016246585 countsByYear W20162465852014 @default.
- W2016246585 countsByYear W20162465852015 @default.
- W2016246585 countsByYear W20162465852016 @default.
- W2016246585 countsByYear W20162465852017 @default.
- W2016246585 countsByYear W20162465852018 @default.
- W2016246585 countsByYear W20162465852019 @default.
- W2016246585 countsByYear W20162465852020 @default.
- W2016246585 countsByYear W20162465852021 @default.
- W2016246585 countsByYear W20162465852022 @default.
- W2016246585 countsByYear W20162465852023 @default.
- W2016246585 crossrefType "journal-article" @default.
- W2016246585 hasAuthorship W2016246585A5021862730 @default.
- W2016246585 hasAuthorship W2016246585A5027225972 @default.
- W2016246585 hasAuthorship W2016246585A5030110134 @default.
- W2016246585 hasAuthorship W2016246585A5042529442 @default.
- W2016246585 hasAuthorship W2016246585A5045943832 @default.
- W2016246585 hasAuthorship W2016246585A5048797041 @default.
- W2016246585 hasAuthorship W2016246585A5074921066 @default.
- W2016246585 hasConcept C126322002 @default.
- W2016246585 hasConcept C128057223 @default.
- W2016246585 hasConcept C16005928 @default.
- W2016246585 hasConcept C168563851 @default.
- W2016246585 hasConcept C197934379 @default.
- W2016246585 hasConcept C203092338 @default.
- W2016246585 hasConcept C2777501473 @default.
- W2016246585 hasConcept C2778329239 @default.
- W2016246585 hasConcept C2780372218 @default.
- W2016246585 hasConcept C2780699399 @default.
- W2016246585 hasConcept C2909675724 @default.
- W2016246585 hasConcept C2911091166 @default.
- W2016246585 hasConcept C71924100 @default.
- W2016246585 hasConceptScore W2016246585C126322002 @default.
- W2016246585 hasConceptScore W2016246585C128057223 @default.
- W2016246585 hasConceptScore W2016246585C16005928 @default.
- W2016246585 hasConceptScore W2016246585C168563851 @default.
- W2016246585 hasConceptScore W2016246585C197934379 @default.
- W2016246585 hasConceptScore W2016246585C203092338 @default.
- W2016246585 hasConceptScore W2016246585C2777501473 @default.
- W2016246585 hasConceptScore W2016246585C2778329239 @default.
- W2016246585 hasConceptScore W2016246585C2780372218 @default.
- W2016246585 hasConceptScore W2016246585C2780699399 @default.
- W2016246585 hasConceptScore W2016246585C2909675724 @default.
- W2016246585 hasConceptScore W2016246585C2911091166 @default.
- W2016246585 hasConceptScore W2016246585C71924100 @default.
- W2016246585 hasIssue "2" @default.
- W2016246585 hasLocation W20162465851 @default.
- W2016246585 hasLocation W20162465852 @default.
- W2016246585 hasOpenAccess W2016246585 @default.
- W2016246585 hasPrimaryLocation W20162465851 @default.
- W2016246585 hasRelatedWork W1991975354 @default.
- W2016246585 hasRelatedWork W2018085374 @default.
- W2016246585 hasRelatedWork W2102642285 @default.
- W2016246585 hasRelatedWork W2114862870 @default.
- W2016246585 hasRelatedWork W2124057002 @default.
- W2016246585 hasRelatedWork W2161672926 @default.
- W2016246585 hasRelatedWork W2317216770 @default.
- W2016246585 hasRelatedWork W2365074602 @default.
- W2016246585 hasRelatedWork W3000863237 @default.
- W2016246585 hasRelatedWork W3195822900 @default.
- W2016246585 hasVolume "62" @default.
- W2016246585 isParatext "false" @default.
- W2016246585 isRetracted "false" @default.
- W2016246585 magId "2016246585" @default.
- W2016246585 workType "article" @default.